Gill-Sharma, M.K., et al., "Effects of Tamoxifen on the Fertility of Male Rats", Journal of Reproduction and Fertility 99, 395-402 (1993). |
Schneider, M. R. et al., "Effect of zindoxifens on experimental prostatic tumours of the rat", J Cancer Res Clin Oncol 117:33-36 (1991). |
Faulkner, et al., "Regional and Total Body Bone Mineral Content, Bone Mineral Density, and Total Body Tissue Composition in Children 8-16 Years of Age" Calcified tissue 53:7-12 (1993). |
Jones, Robert C., "The Effect of a Luteininzing Hormone Releasing Hormone (LRH) Agonist (Wy-40,972), Levonorgestrel, Danazol and Ovariectomy on Experimental Endometriosis in the Rat" Acta Endocrinologica 106, 282-8 (1994). |
Wiseman, H., "Tamoxifen: New Membrane-Mediated Mechanisms of Action and Therapeutic Advances", Tips, 101-15 (1994). |
Wiseman, H., et al., "Droloxifene (3-hydroxytamoxifen) has membrane antioxidant ability: potential relevance to its mechanism of therapeutic action in breast cancer", Cancer Letters, 66 61-68 (1992). |
Steinberg, D., et al., "Beyond Cholesterol Modifications of Low-Density Lipoprotein that increase its Atherogenicity", The New England Journal of Medicine, 915-924 (1989). |
Wiseman, H., et al., Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?, Biochem, J. 292 635 (1993). |
Pritchard, K., "Summary", Am. J. Clin. Oncol., 14 (Suppl. 2) S62-S63 (1991). |
Cypriani, B., et al. "Role of Estrogen Receptors and Antiestrogen Binding Sites in an Early Effects of Antiestrogens, the Inhibition of Cholesterol Biosynthesis", J. Steriod Biochem., vol. 31, No. 5, 763-771, (1988). |
Bruning, P.F., "Droloxifene, A New Anti-estrogen in Postmenopausal Advanced Breast Cancer: Preliminary Results of a Double-blind Dose-finding Phase II Trial", Eur F Cancer, vol. 28A, No. 8/9, 1404-1407 (1992). |
Neubauer, B. L., et al., "Endocrine and Antiprostatic Effects of Raloxifene (LY156758) in Male Rats", The Prostate, 23:245-262 (1993). |
Wiseman, H., et al., "Tamoxifene Inhibits Lipids Peroxidation in Cardiac Microsomes", Biochemical Pharmacology, vol. 45, No. 9, 1851-1855 (1993). |
Love, R. R., "Effects of Tamoxifen on Cardiovascular Risk Factor in Postmenopausal Women", Annals of Internal Medicine, 115, 860-864 (1991). |
Schwartz, J. et al., "Clinical Pharmacology of Estrogens: Cardiovascular Actions and Cardioprotective Benefits of Replacement Therapy in Postmenopausal Women", J. Clin. Pharmacol, 35:314-329 (1995). |
Di Silverio, F., et al., "Pharmacological combinations in the treatment of benign prostatic hypertrophy", Journal d'Urologie, No. 6, 316-320 (1993). |
Bierman, E.L., "Atherosclerosis and other forms of arteriosclerosis", 1106-1110 (1989). |
"Raloxifene Hydrochloride EN=090328", Drugs of the Future, vol. 15(7), 762-63 (1990). |